Miyajima Shinji, Takeda Shotai, Goda Kyosuke, Arasawa Soichi, Hoshi Tomoko, Hoshi Susumu, Tanaka Yuichi, Takaya Haruo, Fukunaga Toyokazu, Kajimura Kozo, Inamoto Osamu
Dept. of Gastroenterology, Kishiwada Municipal Hospital.
Gan To Kagaku Ryoho. 2022 Apr;49(4):437-439.
A 65-year-old woman was admitted to our institution with sonography results indicating a caudate lobe mass. CT showed a large low-density mass in the caudate lobe, extensively involving the inferior vena cava and main portal vein. Moderately differentiated adenocarcinoma was found on transcutaneous biopsy. We therefore regarded this tumor as a severe locally advanced hilar cholangiocarcinoma and initiated gemcitabine/cisplatin combined chemotherapy. The tumor gradually reduced in size. However, after 28 courses of treatment, CT showed persistent tumor invasion in the left trunk of the portal vein and inferior vena cava invasion in succession in the middle; the tumor had not yet invaded the left hepatic vein. Owing to myelosuppression and general malaise, it was difficult to continue chemotherapy. After 32 courses of treatment, the patient underwent a left trisegmentectomy with combined resection of the portal vein and inferior vena cava. Postoperative microscopic findings revealed no apparent invasion of the tumor in the inferior vena cava, thus suggesting successful R0 resection. The patient is alive without recurrence 18 months postoperatively.
一名65岁女性因超声检查结果显示尾状叶肿块而入住我院。CT显示尾状叶有一个大的低密度肿块,广泛累及下腔静脉和门静脉主干。经皮活检发现为中分化腺癌。因此,我们将此肿瘤视为严重的局部晚期肝门部胆管癌,并开始吉西他滨/顺铂联合化疗。肿瘤逐渐缩小。然而,在28个疗程的治疗后,CT显示门静脉左主干持续存在肿瘤侵犯,且下腔静脉中部相继出现侵犯;肿瘤尚未侵犯左肝静脉。由于骨髓抑制和全身不适,难以继续化疗。在32个疗程的治疗后,患者接受了左三叶切除术,并联合切除门静脉和下腔静脉。术后显微镜检查结果显示肿瘤在下腔静脉无明显侵犯,提示R0切除成功。患者术后18个月存活,无复发。